Vetter, a leading provider of aseptically prefilled drug-delivery systems, operates a state-of-the-art facility at the Illinois Science and Technology Park in suburban Chicago. The site offers a central US location with a domestic and international airline hub. It is uniquely situated in a thriving biopharmaceutical region that offers an established infrastructure and prominent research institutions.

The company’s Chicago site supports preclinical through phase 2 development projects. The 27,000-ft² facility’s functional areas include microbiology and chemical analysis laboratories; materials preparation; compounding; aseptic CGMP filling for vials, syringes, and cartridges; quality assurance; and seamless transfer to Vetter commercial manufacturing.

DeveIoped at the urging of Vetter’s North American clients, the Chicago site supports small-batch, early stage products. Vetter has extensive experience working with biologics, including monoclonal antibodies, peptides, interferons, and vaccines.

Supporting a Faster Time to Market

The Chicago facility provides the Vetter approach to product development, which enables a smooth continuum throughout a product’s lifecycle.

Project Management: Across functions and facilities, throughout the development effort, Vetter teams communicate and coordinate using project-management principles. Such a process-driven approach helps keep projects on track and timelines tight. Experienced project managers steer all tasks and processes, which is especially critical in early phase work.

Technology Transfer: Development and commercial teams closely coordinate a product’s transfer from Chicago’s small-scale site to Vetter’s large-scale manufacturing facilities. The Chicago facility replicates commercial-stage processes to help prevent surprises at market production.

Partnership: Client collaboration is one of Vetter’s distinguishing hallmarks. Vetter works closely with its clients to plan for present needs and to set a successful course through registration and long-term market production.

A Full Menu of Development Services

Vetter’s Chicago facility is an expansion of Vetter Development Service, which employs more than 150 people in Europe and the United States and supports customer products from preclinical development through market launch. Its service portfolio includes

Vetter at a Glance

Vetter is a leading contract development and manufacturing organization (CDMO) that specializes in the aseptic filling of syringes, cartridges, and vials. With approximately 3,000 employees worldwide, Vetter holds numerous patents and has longstanding experience in working with regulatory authorities around the world.

Vetter’s international success arises from its three interdependent divisions:

Dr. David Brett is product and service manager, Eywiesenstrasse 5, 88212 Ravensburg, Germany, 0049-751-3700-0, [email protected]; www.vetter-pharma.com.